US Government Stake in Quantum Firms Traders Speculate on IonQ Micron Anduril as Potential Targets Taiwan Emerges as Critical Unspoken Issue in TrumpXi Talks Surge in UK Home Air Conditioning Ownership Signals Shifts in Energy Demand and Consumer Behavior Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement Disaster Discounts Why Home Buyers May Start Demanding Lower Prices in HighRisk Areas Trust Tax Planning How to Minimize Taxes on 300000 Annual Family Trust Income INTU Q1 2026 Earnings EPS Just Misses Estimates Amid Solid Business Momentum PROF Q1 2026 Earnings EPS Surprises to the Upside Stock Declines 2 Oscar Health Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction GROV Q1 2026 Earnings Strong EPS Beat Signals Operational Progress WFC Q1 2026 Earnings EPS Beats Estimates by a Narrow Margin Stock Edges Higher ODYS Q1 2026 Earnings WiderthanExpected Loss Pressures Shares as Revenue Remains Absent Borealis Foods BRLS Edges Higher in Quiet Trading Resistance at 153 in Focus Crane Harbor Acquisition Corp Rights CHACR Rally 1728 as Speculative Interest Drives Price Toward 1 Resistance RF Industries RFIL Gains 37 as Stock Approaches Key Resistance at 1945 Restaurant Brands International QSR Holds Steady Near Support Amid Sector Uncertainty Aemetis Inc AMTX Surges 19 as Renewable Fuel Stock Breaks Resistance Standard Chartered Plans to Reduce Corporate Functions Roles by Over 15 as Part of Efficiency Drive The RealReal REAL Q1 2026 Earnings Narrowing Losses Exceed Estimates Shares Slip K2 Capital Acquisition Corporation Rights KTWOR Hover Near Support Amid Quiet Trading ARCO Q1 2026 Earnings Strong EPS Beat Overshadowed by Stock Decline Whirlpool WHR Q1 2026 Earnings Major EPS Miss Signals Challenging Demand Environment Nuvalent Inc NUVL Q1 2026 Earnings PreRevenue Biotech Narrows Operating Loss Stock Edges higher ZBIO Q1 2026 Earnings NarrowerThanExpected Loss Caps a Quarter of Pipeline Progress COR Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick FBRX Q1 2026 Earnings Narrower Loss But Clinical Path Remains Uncertain STOK Q1 2026 Earnings EPS Surprises to the Upside as Clinical Pipeline Advances